Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

BCS

BCS Investors – A Fast Market Update

Barclays PLC shares fell by -3.6% during the day's morning session, and are now trading at a price of $22.34. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

an Exceptionally Low P/B Ratio but Its Shares Are Expensive:

Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 15.92 and an average price to book (P/B) ratio of 1.78. In contrast, Barclays PLC has a trailing 12 month P/E ratio of 9.4 and a P/B ratio of 0.88.

Barclays PLC's PEG ratio is 1.41, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Exceptional EPS Growth but Positive Cash Flows:

2020 2021 2022 2023 2024 2025
Revenue (M) $8,522 $9,759 $9,494 $9,982 $10,710 $11,110
Interest Income (M) $3,770 $3,167 $8,524 $22,366 $25,390 $21,688
Net Margins 15% 30% 32% 17% 28% 65%
Net Income (M) $1,302 $2,896 $3,063 $1,675 $3,033 $7,213
Depreciation & Amort. (M) $1,539 $1,673 $1,723 $1,784 $1,700 $1,756
Diluted Shares (M) 17,359 16,752 15,871 15,155 14,420 13,867
Earnings Per Share $0.09 $0.36 $0.3 $0.27 $0.35 $0.42
EPS Growth n/a 300.0% -16.67% -10.0% 29.63% 20.0%
Free Cash Flow (M) $57,505 $48,919 $30,231 -$927 $7,113 $18,739
Total Debt (M) $75,796 $98,867,000 $112,881 $96,825 $92,402 $119,033
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS